India has reported a single-day increase of 10,158 new COVID-19 infections, the highest in over 200 days. The active cases in the country have increased to 44,998, while the count of active cases now comprises 0.10% per cent of the total infections. Meanwhile, the national Covid-19 recovery rate has been recorded at 98.71%. According to official sources, the current rise in COVID-19 cases is being driven by XBB.1.16, a sub-variant of the Omicron variant.
The sources also said that even though cases are increasing, hospitalizations are low and expected to remain low. According to official sources, the current rise in Covid cases in India is being driven by XBB.1.16, which is a sub variant of Omicron. Although cases are increasing, hospitalization rates are low and expected to remain low. While Omicron and its sub-lineages continue to be the dominant variant, most of the assigned variants have little or no significant transmissibility, disease severity, or immune escape.It’s good to hear that Serum Institute of India has restarted manufacturing of Covid-19 vaccines and has six million booster doses of Covovax vaccine available. According to CEO Adar Poonawalla, adults must take the booster shot to protect themselves from the virus. It is important for people to follow the guidelines and precautions to prevent the spread of the virus, especially with the rise in cases driven by XBB.1.16 sub variant of Omicron. It is also reassuring to know that despite the increase in cases, there has been no evidence of an increase in hospitalization or mortality.
